Aura Biosciences, Inc.AURA
Price (close)
$6.00
Market cap
$622.2M
P/E
—
Revenue (TTM)
—
Net income
-$131.0M
Dividend yield
—
1-year total return
2.0%
Net margin
—
Revenue growth
—
Debt / equity
—
What Aura Biosciences, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | -$22.2M | -$35.3M | -$58.8M | -$76.4M | -$86.9M | -$106.2M |
| Free cash flow | -$25.1M | -$34.5M | -$55.7M | -$64.6M | -$81.1M | -$85.2M |
More on AURA.
- Aura Biosciences, Inc. summary
- Aura Biosciences, Inc. financial statements
- Aura Biosciences, Inc. key metrics
- Aura Biosciences, Inc. health scores and style box
- Aura Biosciences, Inc. earnings
- Aura Biosciences, Inc. dividends
- Aura Biosciences, Inc. valuation
- Aura Biosciences, Inc. ownership and insiders
- Aura Biosciences, Inc. peers
Figures from Aura Biosciences, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.